🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kristopher R. Bosse

Children's Hospital of Philadelphia

ORCID: 0000-0002-1424-2858

Also affiliated with Pennsylvania Hospital

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.6Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Cell(2020)10.1016/j.cell.2020.03.053
Top 4%
5.6DataRank
Top 4%609 citations

Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska, Jennifer E. Rood +92 more

Papers

Driven by 17 papers — median percentile 96. Top paper: “The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution”.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Cell(2020)10.1016/j.cell.2020.03.053
Top 4%
5.6DataRank
Top 4%609 citations

Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska, Jennifer E. Rood +92 more

Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad183
N/A
1.3DataRank · unranked
27 citations

Zalman Vaksman, Laura E. Egolf, Rebecca S. Kaufman, Perry Evans, Karina L. Conkrite +23 more

Germline pathogenic variants in 786 neuroblastoma patients

medRxiv(2023)10.1101/2023.01.23.23284864
N/A
0.292DataRank · unranked
6 citations

Zalman Vaksman, Laura E. Egolf, Rebecca S. Kaufman, Perry Evans, Karina L. Conkrite +23 more

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN -amplified neuroblastoma

Science Advances(2023)10.1126/sciadv.adg6693
N/A
0.292DataRank · unranked
6 citations

Alberto Delaidelli, Sumreen Javed, Busra Turgu, Taylor Morrison, Christopher S. Hughes +17 more

RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs

Nature(2021)10.1038/s41586-021-04061-6
N/A
0DataRank · unranked
101 citations

Quinlen F. Marshall, John M. Warrington, Rasika Premaratne, Alvin Farrel, David Groff +23 more

A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100344
N/A
0DataRank · unranked
34 citations

Samantha N. Buongervino, Maria Lane, Doncho V. Zhelev, Zhongyu Zhu, Hong Cui +15 more

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.06.451385
N/A
0DataRank · unranked
5 citations

Crystal Griffin, Hakon Hakonarson, Allison Stern, Cameron Brimley, Komal S. Rathi +13 more

Targeting of intracellular oncoproteins with peptide-centric CARs

Nature(2023)10.1038/s41586-023-06706-0
N/A
0DataRank · unranked
79 citations

Quinlen F. Marshall, John M. Warrington, Rasika Premaratne, Alvin Farrel, David Groff +23 more

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

Frontiers in Oncology(2020)10.3389/fonc.2020.00302
N/A
0DataRank · unranked
16 citations

Hakon Hakonarson, Kevin Y. Huang, Pichai Raman, Komal S. Rathi, Daniel Martínez +7 more

BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad182
N/A
0DataRank · unranked
25 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.06.570390
N/A
0DataRank · unranked
5 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Simone Sidoli, Karina L. Conkrite +31 more

BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.31.525066
N/A
0DataRank · unranked
3 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Cancer Cell(2024)10.1016/j.ccell.2024.10.003
N/A
0DataRank · unranked
18 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Karina L. Conkrite, Khushbu Patel +33 more

Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells

Molecular Therapy(2025)10.1016/j.ymthe.2025.05.025
N/A
0DataRank · unranked
11 citations

Sydney L. Roth, Stephanie Matlaga, Evan Cresswell-Clay, Pamela Mishra, Patrick M. Schürch +14 more

LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase

Neoplasia(2020)10.1016/j.neo.2020.04.001
N/A
0DataRank · unranked
30 citations

Julie Cox, Jayabhargav Annam, Melanie Weingart, Grace Essien, Komal S. Rathi +11 more

A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers

Nature Communications(2025)10.1038/s41467-025-62979-1
N/A
0DataRank · unranked
4 citations

Smita Matkar, Christina Acholla, Colleen E. Casey, Grant Li, Martina Mazzeschi +28 more

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Cancer Cell(2021)10.1016/j.ccell.2021.12.005
N/A
0DataRank · unranked
164 citations

Kristopher R. Bosse, Zhongyu Zhu, Doncho V. Zhelev, Robbie G. Majzner, Molly Radosevich +36 more